Filtering by:
Ovarian CancerStudy Does Not Find Link Between Ovarian Cancer and Genital Powder Use
The largest study to date did not find a significant link overall between using powder in the genital area and ovarian cancer in women. However, because of the rarity of ovarian cancer, the study still may not have been large enough to detect a possible small increase in risk, according to the study authors.
Ovarian Cancer Survivor Views Each Day as a Gift
When Mercedes Mundaca was diagnosed with stage 4 ovarian cancer at age 43, her doctor told her she had 4 months to live. That was 6 years ago.
Report: Ovarian Cancer Rates Continue to Decrease
A new report from the American Cancer Society finds rates of ovarian cancer have declined by 29% between 1985 and 2014. Ovarian cancer deaths have declined 33% between 1976 and 2015.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
FDA Approves Lynparza (Olaparib) for Some Ovarian Cancers
The US Food and Drug Administration (FDA) approved Lynparza (olaparib) for women with advanced ovarian cancer caused by a mutated BRCA gene, and who have already had several other treatments.